Gloucester Pharmaceuticals Announces Presentation Of Romidepsin Data At 2007 American Society Of Hematology (ASH) Annual Meeting
Dec 6th 2007Drug InformationPharma Industry
Gloucester Pharmaceuticals, Inc., an oncology focused biopharmaceutical company, announced that two abstracts detailing results from clinical trials of the Company’s lead product candidate, romidepsin, will be presented at the 2007 American Society of Hematology’s 49th Annual Meeting, to be held December 8-11 in Atlanta, Georgia. Dr. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
